Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
254,850
-
Shares change
-
+25,050
-
Total reported value, excl. options
-
$1,267,000
-
Value change
-
+$124,472
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$4.97
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q3 2014
13 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q3 2014.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 254,850 shares
.
Largest 10 shareholders include HealthInvest Partners AB (105,350 shares), SHUFRO ROSE & CO LLC (52,968 shares), GRT CAPITAL PARTNERS LLC (34,467 shares), Essex Financial Services, Inc. (23,776 shares), RENAISSANCE TECHNOLOGIES LLC (17,800 shares), VANGUARD GROUP INC (10,475 shares), MORGAN STANLEY (5,211 shares), BANK OF AMERICA CORP /DE/ (2,032 shares), UBS AG (1,962 shares), and Ground Swell Capital, LLC (395 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.